RSCM
EVH icon

Rock Springs Capital Management’s Evolent Health EVH Stock Holding History

Rock Springs Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Sell
2,500,000
-175,000
-7% -$671K 0.66% 47
2026
Q1 		$6.1M Hold
2,675,000
– – 0.36% 61
2025
Q4 		$10.7M Sell
2,675,000
-275,000
-9% -$1.53M 0.55% 52
2025
Q3 		$25M Buy
2,950,000
+129,300
+5% +$1.25M 1.46% 26
2025
Q2 		$31.8M Buy
2,820,700
+125,000
+5% +$1.15M 1.98% 18
2025
Q1 		$25.5M Buy
2,695,700
+635,700
+31% +$6.42M 1.46% 27
2024
Q4 		$23.2M Sell
2,060,000
-10,000
-0.5% -$176K 0.88% 40
2024
Q3 		$58.5M Sell
2,070,000
-2,007,500
-49% -$51.7M 1.9% 14
2024
Q2 		$78M Buy
4,077,500
+90,000
+2% +$2.3M 2.35% 9
2024
Q1 		$131M Buy
3,987,500
+27,500
+0.7% +$878K 3.32% 4
2023
Q4 		$131M Buy
3,960,000
+95,000
+2% +$2.69M 3.22% 7
2023
Q3 		$105M Buy
3,865,000
+61,500
+2% +$1.71M 2.82% 9
2023
Q2 		$115M Hold
3,803,500
– – 2.74% 9
2023
Q1 		$123M Hold
3,803,500
– – 2.94% 7
2022
Q4 		$107M Buy
3,803,500
+541,000
+17% +$15.5M 2.57% 10
2022
Q3 		$117M Buy
3,262,500
+524,500
+19% +$18.5M 3.03% 8
2022
Q2 		$84.1M Buy
2,738,000
+358,000
+15% +$10.4M 2.45% 8
2022
Q1 		$76.9M Buy
2,380,000
+342,000
+17% +$8.95M 1.94% 13
2021
Q4 		$56.4M Buy
2,038,000
+163,000
+9% +$4.68M 1.3% 23
2021
Q3 		$58.1M Buy
1,875,000
+175,957
+10% +$4.22M 1.22% 27
2021
Q2 		$35.9M Buy
1,699,043
+254,043
+18% +$5.09M 0.71% 50
2021
Q1 		$29.2M Buy
+1,445,000
New +$27.5M 0.64% 54

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rock Springs Capital Management's EVH Position: Q2 2026 in Review

Rock Springs Capital Management reduced its Evolent Health (EVH) stake by 6.5% in Q2 2026, selling an estimated $671K and leaving 2,500,000 shares worth $13.6M. The position accounts for 0.66% of the portfolio, ranked #47.

Rock Springs Capital Management first reported a position in EVH in Q1 2021 and has held it in 22 quarters since. The position peaked at $131M in Q4 2023. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Rock Springs Capital Management held 2,500,000 shares of Evolent Health worth $13.6M as of Q2 2026.
  • Rock Springs Capital Management sold 175,000 Evolent Health shares in Q2 2026, an estimated $671K.
  • Evolent Health made up 0.66% of Rock Springs Capital Management's portfolio in Q2 2026, its #47 holding.
  • Rock Springs Capital Management first reported a position in Evolent Health in Q1 2021 and has held it in 22 quarters since.
  • Rock Springs Capital Management's Evolent Health position peaked at $131M in Q4 2023.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.